News & Events
Innovative Research Brings Potential New Class of Drugs for Patients with ALK-EML4 Fusion
Upcoming Events
Tue, 2/14/2023 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general… more
Thu, 2/16/2023 - 6:30 PM ET
For patients/survivors
General meetup for those impacted by lung… more
Tue, 2/21/2023 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general… more
Thu, 2/23/2023 - 8:00 PM ET
For caregivers, family & friends - You don’t need to take on… more
Tue, 2/28/2023 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general… more
General Virtual Meetup
General Virtual Meetup
Tue, 2/14/2023 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general meetup for those impacted by lung cancer.
After registering, you will receive a confirmation email containing information about joining the meeting.
Thursday Happy Hour Virtual Meetup
Thursday Happy Hour Virtual Meetup
Thu, 2/16/2023 - 6:30 PM ET
For patients/survivors
General meetup for those impacted by lung cancer
Register in advance for this meeting
General Virtual Meetup
General Virtual Meetup
Tue, 2/21/2023 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general meetup for those impacted by lung cancer.
After registering, you will receive a confirmation email containing information about joining the meeting.
Thursday Caregiver Connection
Thursday Caregiver Connection
Thu, 2/23/2023 - 8:00 PM ET
For caregivers, family & friends - You don’t need to take on caregiving alone. Connect with others who share common experiences and build your community of fellow caregivers.
After registering, you will receive a confirmation email containing information about joining the meeting.
General Virtual Meetup
General Virtual Meetup
Tue, 2/28/2023 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general meetup for those impacted by lung cancer.
After registering, you will receive a confirmation email containing information about joining the meeting.